| |
|
Form Serial Number: |
DA20231116E00450
|
| 1.
Date of relevant event: |
13/11/2023
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02269 |
| 4.
Name of listed corporation: |
WuXi Biologics (Cayman) Inc. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
4,255,166,729 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Chen |
| (Other names) |
Zhisheng |
|
|
|
| 10.
Name of director (Chinese): |
陳智勝 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1303 | There has been a change in nature of your interest in the shares because:
you have exercised rights to the shares under equity derivatives |
|
|
|
235,759 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 122,173,893 | 2.87 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 122,173,893 | 2.87 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2307 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4105 | Unlisted derivatives - Physically settled |
| 07/01/2016 | 06/01/2026 | HKD | 1 | USD | 0.167 | | | 85,000,000 |
| Long position | | 4105 | Unlisted derivatives - Physically settled |
| 15/03/2017 | 14/03/2027 | HKD | 1 | USD | 0.340 | | | 17,532,000 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 05/06/2021 | 05/06/2024 | | | | | | | 1,183,800 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 12/11/2022 | 12/11/2025 | | | | | | | 707,278 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 16/06/2023 | 16/06/2026 | | | | | | | 756,160 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 10/06/2024 | 10/06/2027 | | | | | | | 1,324,333 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 10/06/2023 | 10/06/2024 | | | | | | | 877,694 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 24/08/2025 | 24/08/2028 | | | | | | | 522,478 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 24/08/2024 | 24/08/2025 | | | | | | | 957,015 |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| Spouse | Yan Zhao | |
| Child | Emma Lei Chan | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| (private) | Addresses of individuals are not displayed. | | 5103 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Box 28: Represents the restricted shares granted to Dr. Chen pursuant to the Restricted Share Award Scheme and the Share Award Scheme for Global Partner Program adopted by the Company on 15/01/2018 and 16/06/2021 (both amended and restated on 27/06/2023), respectively, and such restricted shares were approved and granted on 05/06/2019, 09/06/2020 (later granted on 12/11/2020), 16/06/2021, 10/06/2022 and 24/08/2023, respectively
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
0
|
|
Date of filing this Form 3A: |
16/11/2023
(dd/mm/yyyy)
|
| |